Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline in Generalized Social Phobia With Comorbidity
NCT00182533Phase 4Terminated
- Sponsor
- Hamilton Health Sciences
- Start
- Jul 2002
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Social Anxiety Disorder (SAD) comparing Sertraline with Placebo (2 arms). Primary endpoints: Clinical Global Impression - Improvement at 16 weeks and Liebowitz Social Anxiety Scale at 16 weeks. Started Jul 2002; status: terminated.
02
Drugs
sertraline
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT00182533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182533.